TEMPEST THERAPEUTICS INC TPST
ASignal's systematic analysis rates TPST as Bearish.
Reflects the latest available analysis · analyzed Nov 14, 2026
The case on TPST
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- RSI indicates oversold condition (26.47), potentially signaling near-term reversal
- MACD histogram is slightly expanding and above signal line, suggesting weakening bearish momentum
- Price is near the lower Bollinger Band, indicating potential support
- Negative price momentum and trading below both SMA20 and SMA50 suggest strong downtrend
- Extremely weak fundamentals: negative ROE (-931.14%), negative margins, and negative free cash flow
- Very low liquidity with current ratio of 0.38x and quick ratio of 0.17x
- High debt level relative to cash: $7.56M debt vs. $779,000 cash
- Limited news coverage from only two sources (Yahoo, Benzinga) and no Reddit mentions
- Negative valuation metrics including negative P/B and negative EV/EBITDA
See the full verdict on TPST
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TPST
Most investors never get a second opinion, let alone several. ASignal runs TPST past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.